![Melissa Downs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Melissa Downs is currently Executive Director-External Communications at Lantheus Holdings, Inc. since 2025.
Formerly, Ms. Downs worked at Progenics Pharmaceuticals, Inc. as Investor Relations Contact.
Aktive Positionen von Melissa Downs
| Unternehmen | Position | Beginn |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01.08.2020 |
Ehemalige bekannte Positionen von Melissa Downs
| Unternehmen | Position | Ende |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Lantheus Holdings, Inc.
 Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
